Uso de talidomida en sangrado recurrente por angiodisplasias gastrointestinales: Caso clínico / Thalidomide for recurrent gastrointestinal bleeding caused by angiodysplasia: Report of one case
Rev. méd. Chile
;
139(7): 909-913, jul. 2011.
Artículo
en Español
| LILACS
| ID: lil-603144
ABSTRACT
Chronic hemodialysis patients may have recurrent bleeding from gastrointestinal angiodysplasia, that often is diffusely located in the digestive tract or in places difficult to reach with traditional endoscopes. Therefore, they cannot be locally treated or removed. We report a 70 years old man on chronic hemodialysis, with severe and persistent anemia due to bleeding from angiodysplasia of the small bowel. Despite administration of high doses of erythropoiesis stimulating agents, intravenous iron, folate, B6 and B12 vitamins, his hemoglobin levels were < 6.5g/dL, becoming totally dependent on transfusions ofred blood cells (up to 46 units per year). Recurrent bleeding was refractory to conventional management and we decided to use thalidomide at doses of 50-100 mg/day achieving rapid control of gastrointestinal bleeding and significant increase of hemoglobin levels, not requiring further transfusions.
Texto completo:
Disponible
Índice:
LILACS (Américas)
Asunto principal:
Talidomida
/
Angiodisplasia
/
Inhibidores de la Angiogénesis
/
Hemorragia Gastrointestinal
/
Intestinos
Tipo de estudio:
Estudio de etiología
Límite:
Anciano
/
Humanos
/
Masculino
Idioma:
Español
Revista:
Rev. méd. Chile
Asunto de la revista:
Medicina
Año:
2011
Tipo del documento:
Artículo
País de afiliación:
Chile
Institución/País de afiliación:
Hospital Naval Almirante Nef/CL
/
Universidad de Valparaíso/CL
Similares
MEDLINE
...
LILACS
LIS